These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10875463)

  • 1. The role of chemotherapy in the management of gastric cancer.
    De Vivo R; Pignata S; Palaia R; Parisi V; Daniele B
    J Clin Gastroenterol; 2000 Jun; 30(4):364-71. PubMed ID: 10875463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
    Ausch C; Rosen HR; Schiessel R
    Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of advanced gastric cancer.
    Wils J
    Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma.
    Alexander HR; Grem JL; Pass HI; Hamilton M; McAtee N; Fraker DL; Allegra CJ
    Oncology (Williston Park); 1993 May; 7(5):37-42; discussion 42-4, 49-50, 53. PubMed ID: 8512781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report.
    Crookes P; Leichman CG; Leichman L; Tan M; Laine L; Stain S; Baranda J; Casagrande Y; Groshen S; Silberman H
    Cancer; 1997 May; 79(9):1767-75. PubMed ID: 9128994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
    Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
    Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.
    Iwahashi M; Nakamori M; Nakamura M; Noguchi K; Ueda K; Nakatani Y; Ojima T; Ishida K; Naka T; Yamaue H
    Anticancer Res; 2005; 25(5):3453-9. PubMed ID: 16101163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer.
    Morant R
    Onkologie; 2001 Apr; 24(2):116-21. PubMed ID: 11441289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative chemotherapy in locally advanced gastric cancer.
    Batista TP; Santos CA; Almeida GF
    Arq Gastroenterol; 2013; 50(3):236-42. PubMed ID: 24322198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant chemotherapy of gastric cancer].
    Shparik IaV
    Klin Khir; 1995; (5):38-41. PubMed ID: 8646632
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perioperative chemotherapy of stomach cancer].
    Preusser P; Wilke H; Fink U; Meyer HJ; Bünte H; Siewert JR
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():125-8. PubMed ID: 1724192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
    Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
    Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy options for gastric cancer.
    Meyerhardt JA; Fuchs CS
    Semin Radiat Oncol; 2002 Apr; 12(2):176-86. PubMed ID: 11979419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Progress in the Adjuvant Treatment of Gastric Cancer.
    Ilson DH
    Surg Oncol Clin N Am; 2017 Apr; 26(2):225-239. PubMed ID: 28279466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyrimidine dehydrogenase activity and mRNA expression in advanced gastric cancer analyzed in relation to effectiveness of preoperative 5-fluorouracil-based chemotherapy.
    Takabayashi A; Iwata S; Kawai Y; Kanai M; Taki Y; Takechi T; Fukushima M
    Int J Oncol; 2000 Nov; 17(5):889-95. PubMed ID: 11029488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
    Yonemura Y; Bandou E; Sawa T; Yoshimitsu Y; Endou Y; Sasaki T; Sugarbaker PH
    Eur J Surg Oncol; 2006 Aug; 32(6):661-5. PubMed ID: 16621433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.